Literature DB >> 2221091

Glomerular response to hyperglycemia in human diabetic nephropathy.

A Remuzzi1, G Viberti, P Ruggenenti, C Battaglia, R Pagni, G Remuzzi.   

Abstract

We have studied the effect of acute hyperglycemia on glomerular function in seven insulin-dependent diabetics with overt nephropathy during hyperglycemic or euglycemic clamp. In all patients glomerular filtration rate (GFR) was higher during hyperglycemia than during euglycemia (35.0 +/- 15.5 vs. 21.4 +/- 10.3 ml.min-1.1.73 m-2, P less than 0.01), whereas renal plasma flow did not change significantly. To establish which determinant of GFR is altered by hyperglycemia, fractional clearances of neutral dextrans of graded molecular size were determined in both glycemic states, and data were analyzed by a theoretical model of hindered transport of macromolecules through a porous membrane. Hyperglycemia significantly increased sieving coefficients of small dextran molecules (28-40 A in radius), whereas fractional clearances of large macromolecules (greater than 44 A) did not change. Theoretical analysis suggested that the ultrafiltration coefficient (Kf) and membrane permeability to small dextrans (less than 40 A) increased in hyperglycemia in respect to euglycemia. Because these results have been obtained in patients with severe renal failure and hypertension, our conclusions do not necessarily apply to the early phase of diabetic nephropathy.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2221091     DOI: 10.1152/ajprenal.1990.259.4.F545

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  8 in total

1.  Permselectivity in thin membrane nephropathy.

Authors:  D M Thomas; G A Coles; D F Griffiths; J D Williams
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

2.  Results of pancreas transplantation alone with special attention to native kidney function and proteinuria in type 1 diabetes patients.

Authors:  Ugo Boggi; Fabio Vistoli; Gabriella Amorese; Rosa Giannarelli; Alberto Coppelli; Rita Mariotti; Lorenzo Rondinini; Massimiliamo Barsotti; Alberto Piaggesi; Anna Tedeschi; Stefano Signori; Nelide De Lio; Margherita Occhipinti; Emanuela Mangione; Diego Cantarovich; Stefano Del Prato; Franco Mosca; Piero Marchetti
Journal:  Rev Diabet Stud       Date:  2011-08-10

3.  Glomerular resistances predict long-term GFR decline in type 2 diabetic patients without overt nephropathy: a longitudinal subgroup analysis of the DEMAND trial.

Authors:  Fabiola Carrara; Piero Ruggenenti; Annalisa Perna; Ilian Petrov Iliev; Flavio Gaspari; Silvia Ferrari; Nadia Stucchi; Antonio Bossi; Roberto Trevisan; Giuseppe Remuzzi; Aneliya Parvanova
Journal:  Acta Diabetol       Date:  2021-10-14       Impact factor: 4.280

Review 4.  Glomerular hyperfiltration.

Authors:  Monica Cortinovis; Norberto Perico; Piero Ruggenenti; Andrea Remuzzi; Giuseppe Remuzzi
Journal:  Nat Rev Nephrol       Date:  2022-04-01       Impact factor: 42.439

5.  Glucose-induced changes in renal haemodynamics in proteinuric type 1 (insulin-dependent) diabetic patients: inhibition by acetylsalicilic acid infusion.

Authors:  S De Cosmo; K Earle; A Morocutti; J Walker; P Ruggenenti; G Remuzzi; G C Viberti
Journal:  Diabetologia       Date:  1993-07       Impact factor: 10.122

6.  Decline in the estimated glomerular filtration rate (eGFR) following metabolic control and its relationship with baseline eGFR in type 2 diabetes with microalbuminuria or macroalbuminuria.

Authors:  Shoichi Akazawa; Eiji Sadashima; Yasunori Sera; Nobuhiko Koga
Journal:  Diabetol Int       Date:  2021-07-29

Review 7.  Acarbose: safe and effective for lowering postprandial hyperglycaemia and improving cardiovascular outcomes.

Authors:  James J DiNicolantonio; Jaikrit Bhutani; James H O'Keefe
Journal:  Open Heart       Date:  2015-10-19

8.  The Chronic Kidney Disease-Epidemiology Collaboration (CKD-EPI) equation does not improve the underestimation of Glomerular Filtration Rate (GFR) in people with diabetes and preserved renal function.

Authors:  Richard J MacIsaac; Elif I Ekinci; Erosha Premaratne; Zhong X Lu; Jas-Mine Seah; Yue Li; Ray Boston; Glenn M Ward; George Jerums
Journal:  BMC Nephrol       Date:  2015-12-03       Impact factor: 2.388

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.